Major depressive disorder (MDD) is considered a 'circuitopathy', and brain stimulation therapies hold promise for ameliorating MDD symptoms, including hippocampal dysfunction. It is unknown whether stimulation of upstream hippocampal circuitry, such as the entorhinal cortex (Ent), is antidepressive, although Ent stimulation improves learning and memory in mice and humans. Here we show that molecular targeting (Ent-specific knockdown of a psychosocial stress-induced protein) and chemogenetic stimulation of Ent neurons induce antidepressive-like effects in mice. Mechanistically, we show that Ent-stimulationinduced antidepressive-like behavior relies on the generation of new hippocampal neurons. Thus, controlled stimulation of Ent hippocampal afferents is antidepressive via increased hippocampal neurogenesis. These findings emphasize the power and potential of Ent glutamatergic afferent stimulation-previously well-known for its ability to influence learning and memoryfor MDD treatment.
A ntidepressant medications are widely used to treat major depressive disorder (MDD), but 50% of patients with depression who receive these medications relapse, and 30% are drug-resistant 1, 2 . MDD is marked by disordered activity of neuronal circuits that regulate mood, cognition, perception, reward, and motor function. However, both deep brain stimulation (DBS) and more superficial stimulation approaches (i.e., transcranial direct current stimulation (tDCS), transmagnetic stimulation (TMS), and electroconvulsive therapy (ECT)) have drawbacks, including cognitive side effects, seizures, and a high rate of relapse after remission 3 . Therefore, more treatments for MDD are needed, particularly stimulation therapies that more precisely target depression-linked dysfunctional circuitry.
Notable hallmarks of MDD are the structural and functional deficits apparent in the hippocampus, a brain region linked to mood regulation and memory. For example, depressed humans and chronically stressed animals have reduced hippocampal activity and volume and decreased expression of activity-dependent genes and processes, including reduced adult neurogenesis in the hippocampal dentate gyrus (DG) 4, 5 . These hippocampal deficits have long been the target of depression treatments in an effort to ameliorate depression symptoms 5, 6 . Interestingly, DBS of a major source of hippocampal inputs, the entorhinal cortex (Ent), enhances hippocampal-dependent memory in humans and mice and increases DG neurogenesis in rodents 7, 8 . Although Ent volume is decreased in late-onset and remitted MDD 9 , it is unknown whether specific stimulation of Ent-DG afferents combats the symptoms of depression.
Here we used molecular and chemogenetic approaches to test whether Ent-DG stimulation is antidepressive in mice. For the molecular approach, we targeted tetratricopeptide-repeat-con-taining RAB8b-interacting protein (TRIP8b, also called PEX5R), a brain-specific auxiliary subunit of the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel 10 . TRIP8b splice variants differentially regulate cell surface expression of HCN channels and their hyperpolarization-activated current (I h ) [11] [12] [13] . Notably, disruption of TRIP8b (germline knockout) or HCN1 function (hippocampal-specific knockdown) increases the excitability of hippocampal neurons and results in antidepressive-like behavior 11, 14 . Using viralmediated knockdown of TRIP8b in Ent neurons, we found that disinhibited Ent afferents to the DG drive activity-dependent processes in the DG and facilitate antidepressive-like behavior under both basal and stressful conditions. Mechanistically, we found that this antidepressive-like behavior was dependent on adult hippocampal neurogenesis. As our viral-mediated TRIP8b knockdown targeted all neurons in the Ent, we next used viral-mediated gene transfer, transgenic mice, and chemogenetics 15 to determine whether stimulation specifically of glutamatergic Ent-DG circuitry drove antidepressive-like behavior. We found that chronic stimulation of glutamatergic afferents from the Ent to the DG ameliorates behavioral symptoms of depression under both acute and chronic stressful conditions.
Results
Trip8b germline knockout mice have increased dentate gyrus neurogenesis and dendritic morphology relative to wild-type mice. Hippocampal neurons fire more frequently in Trip8b germline knockout mice owing to lack of I h 11 , and Trip8b germline knockout mice display antidepressive-like behavior 11 . Given the links among antidepressive-like behavior, hippocampal activity, and DG neurogenesis 5 , we hypothesized that Trip8b germline knockout in TRIP8b-shRNA-transfected EGFP + stellate cells than in SCR-shRNA-transfected EGFP + stellate cells and neighboring EGFPstellate cells in both TRIP8b-shRNA-infused and SCR-shRNA-infused mice (Fig. 2g,h and Supplementary Fig. 4c -e), resulting in overall increased neuronal excitability. As brain stimulation approaches can have drawbacks, such as seizure induction or abnormal brain activity, in vivo electroencephalogram (EEG) recordings were performed in awake and behaving male and female mice 5 weeks after viral infusion in the Ent (Fig. 2i ). In vivo EEG recordings revealed no abnormal or epileptiform activity in the cortex or the hippocampus, as power spectral density analysis showed similar brain activity in SCR-shRNA-and TRIP8b-shRNA-infused mice (Fig. 2i,j and Supplementary Fig. 4f,g) . Neither SCR-shRNA-nor TRIP8b-shRNA-infused mice showed the epileptiform-like activity in the cortical-hippocampal network that was seen in pilocarpine-treated mice (Fig. 2j ).
Having established in vitro and in vivo efficacy and the lack of abnormal activity in the cortical-hippocampal network, we next assessed the ability of Ent-specific knockdown of TRIP8b to promote an activity-dependent process in the DG, such as DG neurogenesis. Four weeks after viral infusion in the Ent, EGFP + DG molecular layer terminals were evident ( Fig. 2k-m and Supplementary Fig. 5a h). Ent-specific TRIP8b knockdown enhanced several indices of DG neurogenesis and new neuron maturation ( Fig. 2n-w) , as there were 11% more doublecortin (DCX) + cells (Fig. 2n,o) , 55% more surviving BrdU + cells ( Fig. 2p-q) , and 64% more BrdU + NeuN + neurons ( Fig. 2r,s) in the DG of TRIP8b-shRNA-infused mice versus SCR-shRNA-infused mice, but there was no change in the number of type-1 neural stem cells ( Supplementary Fig. 6 ). Dendritic reconstruction of DCX + cells showed dendrites that were 23% longer and Uncropped blots are provided in Supplementary Fig. 3a 
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had 25% more nodes and 20% more ends ( Fig. 2t -w) 20, 21 in TRIP8b-shRNA-infused mice versus SCR-shRNA-infused mice. Thus, TRIP8b knockdown in Ent-DG afferents enhanced both the generation and dendritic maturation of adult-generated DG neurons.
Entorhinal cortex-specific TRIP8b knockdown promotes antidepressive-like behavior that is neurogenesis-dependent. As TRIP8b knockdown in the Ent-DG circuit enhanced DG neurogenesis-an activity-dependent process-and Trip8b germline knockout mice exhibited antidepressive-like behavior, we next hypothesized that Ent-specific TRIP8b knockdown would promote antidepressive-like behavior. Eight-week-old male mice received bilateral infusion of TRIP8b shRNA or SCR shRNA in the Ent. Four weeks later, these mice were tested for locomotor behavior and then examined in the forced swim test or for contextual fear conditioning ( Fig. 3a ). Compared to SCR-shRNA-infused mice, TRIP8b-shRNA-infused mice showed normal locomotor activity ( Fig. 3b) but displayed antidepressive-like behavior, spending 17% less time immobile in the forced swim test ( Fig. 3c ). As the Ent-DG circuit is also involved in context-dependent memory 7 , we hypothesized that Ent-specific TRIP8b knockdown would promote hippocampal-dependent memory after contextual fear conditioning. Indeed, TRIP8b-shRNA-infused mice displayed 51% more freezing in the shock-paired context versus SCR-shRNA-infused mice ( Fig. 3d ), with no difference in results from the cue test ( Fig. 3e ). Thus, Entspecific TRIP8b knockdown indeed improved hippocampal-dependent memory. Multiple lines of evidence implicate DG adult neurogenesis in antidepressant efficacy, particularly under stressful conditions [22] [23] [24] [25] . Thus, the Ent-specific TRIP8b-knockdown-induced increase in neurogenesis may have been a causative factor in driving antidepressive-like behavior. However, it is also possible that the Ent-specific TRIP8b-knockdown-induced increase in neurogenesis observed here was merely correlated with the Ent-specific 
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TRIP8b-knockdown-induced antidepressive-like behavior, particularly after stress. To distinguish between these two possibilities, 7-week-old male mice received Ent infusion of TRIP8b shRNA or SCR shRNA, which was followed 1 week later by sham irradiation or DG-directed image-guided X-ray irradiation to ablate neurogenesis ( Fig. 3f ). Four weeks after irradiation, mice were assessed for locomotor activity and were subjected to the forced swim test after a brief restraint stress ( Fig. 3f -j). As expected, ablation of neurogenesis did not change locomotor activity ( Fig. 3i and Supplementary Fig. 7a ). However, TRIP8b-shRNA-infused mice spent less time immobile in the forced swim test than the SCR-shRNA-infused mice, whereas DG-directed irradiation significantly blunted the antidepressivelike behavior inducedby Ent-specific TRIP8b knockdown ( Fig. 3j and Supplementary Fig. 7b ).
Entorhinal cortex-specific TRIP8b knockdown promotes antidepressive-like behaviors under conditions that mimic chronic stress. As TRIP8b knockdown in the Ent-DG circuit enhances antidepressive-like behavior under basal conditions and after a brief stress ( Fig. 3c ,j), we next hypothesized that TRIP8b knockdown in the Ent-DG circuit would enhance antidepressive-like behavior under conditions that mimic chronic stress, such as longterm exposure to the stress hormone corticosterone [26] [27] [28] [29] . To test this hypothesis, 7-week-old female mice received Ent infusion of TRIP8b shRNA or SCR shRNA, and one week later, they began to receive chronic administration of corticosterone or vehicle (0.45% 2-hydroxypropyl-β -cyclodextrin; Fig. 4a ). Behavioral testing for locomotion and anxiety-and antidepressive-like behavior-assessed through novelty-suppressed feeding as well as the forced swim testbegan 4 weeks after viral infusion and 3 weeks into chronic corticosterone administration ( Fig. 4b-g and Supplementary Figs. 8 and 9 ). Neither chronic corticosterone administration nor Ent-specific TRIP8b knockdown changed locomotor activity ( Fig. 4b ) or basal anxiety-like behavior in the dark-light test or in the elevated plus maze (Fig. 4c,d and Supplementary Fig. 9a-d ). However, latency to feed in the novelty-suppressed feeding test was increased in mice that were chronically administered corticosterone relative to mice treated with vehicle ( Supplementary Fig. 8a ), and Ent-specific TRIP8b knockdown blocked this corticosterone effect ( Fig. 4e and Supplementary Fig. 8a ). Ent-specific TRIP8b knockdown did not change the corticosterone-induced effect on food consumption in mice in the home cage following novelty-suppressed feeding ( Fig. 4f ). Similarly, chronic corticosterone increased the time spent immobile in the forced swim test relative to mice treated with vehicle, whereas Ent-specific TRIP8b knockdown blocked this effect ( Fig. 4g and Supplementary Fig. 8b ). One interpretation of these data is that Ent-specific TRIP8b knockdown promotes antidepressive-like behaviors under conditions that mimic chronic stress, but it is also possible that these effects are due to the action of Ent projections to other brain and hippocampal regions. However, analysis of behavioral data from mice that had additional 'off-target' expression (for example, terminal expression in hippocampal CA1 or CA2/CA3) revealed no antidepressive-like behavior in the forced swim test at baseline or after acute or chronic stress ( Supplementary Fig. 5i -k). Thus, these data support the interpretation that TRIP8b knockdown in the Ent-DG circuit-and not in other brain or hippocampal areas-promotes antidepressive-like behavior.
Chronic stimulation of entorhinal cortex glutamatergic afferents drives dentate gyrus activity-dependent processes, but not abnormal network activity. Disinhibition of the Ent-DG circuit through TRIP8b knockdown promotes antidepressive-like behavior, suggesting that our manipulation was ultimately stimulating Ent excitatory neurons. To test whether stimulation of glutamatergic 30 -and not nonglutamatergic 31 Articles NaTurE MEDIcINE to the DG are responsible for the observed effects, we used a chemogenetic approach 15 to control excitability of glutamatergic neurons in the Ent. Seven-week-old male and female mice expressing Cre recombinase under control of a CamKIIα promoter (CamKIIα -iCre mice 32 ) received Ent infusion of a Cre-recombinase-dependent virus containing either the construct for the designer Gq-coupled modified human M3 muscarinic receptor (AAV-hSyn-DIO-hM3Dq-mCherry; referred to as 'hM3Dq') or a reporter construct (AAV-hSyn-DIO-mCherry; referred to as 'mCherry') 33 (Fig. 5a ).
Supporting appropriate targeting of the Ent-DG circuit (Fig. 5b,c and Supplementary Fig. 10a-h) , CamKIIα -iCre-driven mCherry expression was evident in Ent cell bodies and DG molecular layer terminals of both hM3Dq-infused and mCherry-infused mice (Fig. 5c ). After 4 weeks of daily administration of the designer ligand clozapine-N-oxide (CNO, intraperitoneal (i.p.)), c-Fos + cells were more abundant (suggesting more neural activity) in the Ent and DG of hM3Dq-infused mice relative to mCherry-infused mice (Fig. 5d ,e and Supplementary Fig. 10i,j) . The increase in c-Fos + cell number was hippocampal-subregion-specific, as there were 56% more c-Fos + cells in the DG of hM3Dq-infused mice than in mCherry-infused mice, but there was no difference in the number of c-Fos + cells in the CA1 and CA2/CA3 of hM3Dq-infused mice versus mCherry-infused mice ( Fig. 5e ). Stimulation of the Ent-DG circuit also increased DG neurogenesis, with 65% more BrdU + cells and 129% more BrdU + NeuN + neurons in hM3Dq-infused mice than in mCherry-infused mice ( Fig. 5f -j).
As stimulation of Ent-DG glutamatergic afferents might produce abnormal or epileptiform brain activity 34 , we recorded cortical and hippocampal EEG of male and female CamKIIα -iCre mice that received hM3Dq or mCherry viral infusion into the Ent at 7 weeks of age and received CNO (1 mg per kg body weight (mg/kg), daily i.p., 5 weeks; Supplementary Fig. 11a ) beginning 3 weeks later. In vivo EEG recordings of these awake and behaving mice revealed no aberrant epileptiform or hippocampal network activity after 5 weeks of CNO (1 mg/kg; Supplementary Fig. 11a -c,e-g) and no measurable difference in hippocampal network activity between hM3Dq mice and mCherry mice, even across the day-night cycle ( Supplementary  Fig. 11e -g). However, CNO-treated hM3Dq-infused mice given a single high dose of CNO (10 mg/kg) showed epileptiform activity ( Supplementary Fig. 11d ). These data reveal that hM3Dq-infused mice and mCherry-infused mice had similar hippocampal activity and support our ability to finely tune the activity of the Ent-DG circuit depending on the CNO dose.
Chronic stimulation of glutamatergic entorhinal cortical afferents to the dentate gyrus ameliorates behavioral symptoms of stress-induced depression. Having established that stimulation of the glutamatergic Ent-DG circuit enhances DG cellular activity and activity-dependent processes without driving abnormal brain network activity, we examined whether chronic chemogenetic stimulation of glutamatergic cells in the Ent drove antidepressive-like behaviors 24, 35 . Seven-week-old CamKIIα -iCre male mice received infusion of hM3Dq or mCherry in the Ent. Three weeks later, mice began to receive daily administration of CNO for 5 weeks (Fig. 5k ). Locomotor activity in hM3Dq-infused mice was similar to mCherry-infused mice when examined after 4 weeks of CNO treatment ( Fig. 5l ). However, in the novelty-suppressed feeding test performed after 5 weeks of CNO, hM3Dq-infused mice displayed a 47% shorter latency to feed versus mCherry-infused mice ( Fig. 5m ), suggesting an antidepressive-like effect. This was a specific effect, as after the novelty-suppressed feeding test, both hM3Dq-and mCherry-infused mice consumed the same amount of food in the home cage ( Fig. 5n) . In contrast to the antidepressive-like behaviors seen in hM3Dq mice after chronic CNO injections, hM3Dq-and in mCherry-and hM3Dq-infused mice. n = 5 mCherry-infused mice, 5 hM3Dq-infused mice. Statistical analysis was performed using an unpaired t-test in g and j: **P < 0.01, ***P < 0.001; a two-way ANOVA was used in h: effects of bregma, F 13,364 = 27.90, P < 0.0001; treatment, F 1,364 = 51.07, P < 0.0001; and bregma × treatment interaction, F 13,364 = 2.901, P < 0.001. Bonferroni post hoc analysis was performed for treatment in h: a, P < 0.05; a′ , P < 0.01; a′ ′ P < 0.001. k, The timeline of studies on behavior induced by chronic chemogenetic stimulations. l, hM3Dq-infused mice had similar locomotor activity (time of day shown on x axis) relative to mCherry-infused mice before and after daily chronic CNO injection. Statistical analysis was performed using a two-way repeated-measures ANOVA in l: effects of time, F 79,1580 = 10.75, P < 0.0001; treatment, F 1,20 = 0.7316, P > 0.05; subjects, matching, F 20,1580 = 3.971, P < 0.0001; and time × treatment interaction, F 79,1580 = 0.2065, P > 0.9999. m,n, hM3Dq-infused mice had a shorter latency to feed in the novelty-suppressed feeding test than the mCherry-infused mice (m), but food consumption in the home cage was similar between the groups (n). For l-n, n = 8 mCherry-infused mice, 7 hM3Dq-infused mice. Statistical analysis with an unpaired t-test was used in m and n: *P < 0.05. o, The timeline of studies on behavior induced by acute chemogenetic stimulation. p, hM3Dq-infused mice had similar locomotor activity (time of day shown on x axis) relative to mCherry-infused mice before and after CNO injection. Statistical analysis was performed using a two-way repeated-measures ANOVA in p: effects of time, F 79,1106 = 14.82, P < 0.0001; treatment, F 1,14 = 0.7466, P > 0.05; subjects, matching, F 14,1106 = 9.23, P < 0.0001; and time × treatment interaction, F 79,1106 = 0.7006, P > 0.05. q,r, hM3Dqand mCherry-infused mice had a similar latency to feed in the novelty-suppressed feeding test (q) and similar food consumption in the home cage (r). Statistical analysis was performed using an unpaired t-test in q and r; P > 0.05. For p-r, n = 7 mCherry-infused mice, 9 hM3Dq-infused mice. s, The timeline of CSDS. t, Ten days of CSDS decreased the time of SI in mCherry-infused mice relative to mCherry-infused control mice. However, chronic stimulation of the Ent in hM3Dq mice increased the time of SI relative to mCherry-infused mice that received CSDS.n = 6 mCherry/Control mice, 6 hM3Dq/Control mice, 16 mCherry/CSDS mice, 12 hM3Dq/CSDS mice. A two-way repeated-measures ANOVA was used for statistical analysis in t: effects of target, F 1,36 = 7.494, P < 0.01; virus, F 3,36 = 3.155, P < 0.05; subjects, matching, F 36,36 = 2.242, P < 0.01; and target × virus interaction, F 3,36 = 2.132, P > 0.05. Fisher's LSD post hoc analysis was performed for virus: *P < 0.05, **P < 0.01. Data are shown as mean ± s.e.m. in e, g, h, j, l-n, p-r, and t with data points from individual mice in e, g, j, m, n, q, r, and Articles NaTurE MEDIcINE mCherry-infused male mice that were given an acute CNO treatment (2 mg/kg) 3 weeks following viral infusion (Fig. 5o ) showed similar locomotor behavior and latency to feed ( Fig. 5p-r) .
Finally, we hypothesized that chronic stimulation of glutamatergic afferents from the Ent to the DG would enhance antidepressivelike behavior under conditions of an ethologically relevant chronic social stress, such as CSDS 18, 36, 37 . To test this hypothesis, 7-weekold CamKIIα -iCre male mice received Ent infusion of hM3Dq or mCherry, began to receive daily CNO injections 3 weeks after viral infusion, and began 10 d of CSDS or control housing (housed in partitioned cage with conspecific instead of aggressor) 4 weeks into the CNO regimen (Fig. 5s ). SI testing revealed that, although there were no differences among groups when a social target was absent (Fig. 5t) , mCherry-infused mice that underwent CSDS had less interaction with a social target than nonstressed mCherryinfused mice, as expected. In addition, hM3Dq-infused mice that underwent CSDS had more interaction time with a social target than mCherry-infused mice that underwent CSDS (Fig. 5t ). Taken together, our findings show that stimulation of glutamatergic neurons in the Ent-DG circuit is antidepressive, even in an animal model of stress-induced depression.
Discussion
The Ent-hippocampal circuit is well-known for its role in processing episodic memory of spatial and object information 38, 39 , and recent research shows that Ent stimulation has physiological benefits in learning-and memory-related processes in humans. For example, in humans, Ent DBS enhances spatial learning and is accompanied by resetting of hippocampal theta rhythms 8 . In contrast, direct DBS of the human hippocampus either does not affect or negatively influences hippocampal-dependent memory 8, 40 , emphasizing the utility of targeting hippocampal input rather than the hippocampus itself. In addition to this work in humans, preclinical work also supports the idea that DBS of the Ent improves spatial learning and memory, specifically driving activity-dependent adult neurogenesis in the mouse hippocampus 7 . Our present work supports this, as we show stimulation of Ent-DG circuitry in mice improves hippocampaldependent memory. However, our main goal was to test the new hypothesis that Ent stimulation would be effective in ameliorating depressive-like behaviors. This hypothesis was inspired by the Ent and hippocampal structural deficits seen in the brains of humans with MDD and in animal models of depression 4, 5, 9 and by the ability of many antidepressant drugs and even nonpharmacological treatments, like ECT, to ameliorate these structural deficits [41] [42] [43] . In support of our hypothesis, we show both molecular-and chemogenetic-based stimulation of Ent-DG circuitry in mice combats stress-induced depressive-like behavior. For any new therapeutic, it is critical to consider the intensity and duration of treatment. Interestingly, prior work showed longer-term-but not acute-Ent DBS improved learning-and memory-related function of the hippocampus 7, 8, 40 . Our present work also shows that chronic-but not acute-Ent stimulation drives antidepressive-like behaviors in mice. It remains to be tested how long the Ent-stimulation-induced memory enhancement and antidepressive-like behavior persist. Importantly, it also remains unknown whether Ent stimulation will alleviate MDD symptoms in humans. However, our findings in laboratory mice emphasize the power and potential of Ent glutamatergic afferent stimulation-previously known for the ability to positively influence learning and memory-for the treatment of MDD.
In light of the efficacy of Ent stimulation for both the alleviation of stress-induced depressive-like behavior in mice described here and for improvement of learning-and memory-related processes in both mice and humans 7, 8 , it is notable that many psychiatric disorders (MDD, bipolar disorder, schizophrenia, post-traumatic stress disorder, and substance-use disorders) share symptoms reminiscent of abnormal DG function: dysregulated memory, mood regulation, pattern separation, and reward processing. Future studies are warranted to examine whether Ent stimulation broadly normalizes DG function and thus ameliorates symptoms in other disorders aside from MDD. In addition, given the functional heterogeneity of the mammalian hippocampus 44 , it will be important to assess whether targeting subregions of the Ent results in specific functional outcomes or whether the entire perforant path needs to be engaged. This is particularly true considering that anxiety-like behaviors rely on both the dorsal and ventral DG 44 . Also, it remains unknown whether the functions of the DG closely relate to each other, such that improvement in mood regulation, for example, also improves memory. A corollary of this is whether or not Ent stimulation will improve DG functions that are far less studied, such as contextual pattern separation and reward processing. For example, disruption of Ent via excitotoxic lesion also disrupts pattern separation 45 , and an inducible increase of adult DG neurogenesis improves pattern separation 46 , but it remains to be seen whether stimulation of the Ent-DG circuit improves pattern separation.
Mechanistically, we show that Ent-stimulation-induced antidepressive-like behavior relies on intact DG neurogenesis. These data are in line with causative studies in mice showing newly generated DG neurons are required for antidepressant efficacy, particularly under stressful conditions 24, 35, 47 . Although 'increased hippocampal neurogenesis' has been proposed to even underlie the effectiveness of certain antidepressants 48, 49 , it has thus far been unclear how this action was achieved. Our results showing that stimulation of Ent-DG circuitry spurs adult hippocampal neurogenesis and drives antidepressant behavior raise the possibility that these actions could be harnessed to improve mood more effectively and/or enhance resilience in the face of stressful situations.
Our findings provide the first evidence to our knowledge that the Ent-DG circuit may be targeted for depression treatment, with chronic-but not acute-stimulation driving antidepressive-like behaviors. The ability to produce antidepressive-like behaviors by stimulating the Ent-DG circuitry fits well with the modern framing of depression as a circuitopathy 50 . As stimulation of the Ent-DG circuitry enhances hippocampal function relevant to mood and memory, targeting this new circuit for MDD treatment may preclude side effects of currently employed brain stimulation therapies (i.e., memory loss and cognitive impairment) and will address the great demand for new avenues of treatment for humans who are affected by MDD.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41591-018-0002-1.
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across multiple days, data from multiple days were averaged for each designated time period. Experimenters remained blind throughout quantification and analysis of data.
Image-guided cranial irradiation. Image-guided cranial irradiation was delivered via the X-RAD 225Cx self-contained irradiation system (Precision X-Ray) as previously published 25, 58 . Briefly, 8-week-old male C57BL/6 J mice were anesthetized with 1.5-2.5% isoflurane. Mice received diagnostic imaging to align the body and bregma coordinates with the collimator (6 mm × 14 mm rectangular collimator) to ensure hippocampal targeting. Mice then received image-guided cranial irradiation (10 Gy, 225 Kv, 13 mA, 207 s). Control mice (sham) were handled in the same manner as irradiated mice (for example, exposed to isoflurane for the same period of time), except they were not placed in the irradiator.
Tissue collection and western blot. Brains and adrenal glands from decapitated mice were immediately dissected and frozen on dry ice (Fig. 1) . Supplementary  Fig. 3h includes data only from mice with successful bilateral extraction of adrenal glands. For western blot quantification of the levels of TRIP8b isoforms, brains were sectioned coronally at 300 µ m using a cryostat (Leica) through the A/P length of the hippocampus 59 . The hippocampal DG (distance range from bregma: -1.34 mm to -2.54 mm) was sampled (0.8-mm diameter punch, Fine Science Tools, Foster City, CA), and tissues were homogenized in RIPA Buffer (150 mM NaCl, 1% NP-40, 0.5% deoxycholic acid, 0.1% SDS, and 50 mM TRIS, pH 8.0) with protease inhibitors (Roche, Indianapolis, IN). Protein concentration was determined using the BCA Protein Assay Reagent (Pierce, Rockford, IL). 20 µ g of protein was electrophoretically separated on a 7.5% Tris-acetate gel and transferred to nitrocellulose membranes (Millipore, Billerica, MA). After transferring proteins from gel to nitrocellulose membrane, membranes were horizontally cut to enable immunoblotting for proteins on subsections of membrane. Membranes were incubated with primary antibodies against rabbit anti-TRIP8b (total, from D.M.C.), guinea pig anti-TRIP8b (1a5, from D.M.C.), mouse anti-TRIP8b (exon 4, Neuromab, cat. no. 73-208), mouse anti-TRIP8b (1b, Neuromab, cat. no. 73-245), or mouse anti-GAPDH (Millipore, cat. no. MAB374). Appropriate HRP-conjugated donkey anti-rabbit IgG (Calbiochem, cat. no. 401393), HRPconjugated donkey anti-guinea pig IgG (Jackson ImmunoResearch Laboratories, cat. no. 106-035-003), and HRP-conjugated donkey anti-mouse IgG secondary antibodies (Calbiochem, cat. no. 401253) were used. Immunoreactive proteins were detected via chemiluminescent substrate (Thermofisher Scientific, cat. no. 34077) using X-ray film (Phenix Research Product, cat. no. F-BX810). Stripping and reprobing was used only for the membrane subsection blotted first for IsoA5 and subsequently for TRIP8b. Stripping of IsoA5 was performed using Restore Western Blot Stripping Buffer (Thermo Fisher Scientific, cat. no. 21059) following the manufacturer's instructions, and the blot was then incubated with anti-TRIP8b antibody (total, from D.M.C.). Images of immunoreactive bands were captured using a 3CCD color video camera (Sony, cat. no. DCX-3900), and the intensities were analyzed through densitometry using Scion image software (Scion Corporation). The measurements of immunoreactivity for each protein of interest were normalized to GAPDH in each sample.
To test the efficiency of in vitro TRIP8b knockdown, HEK293T cells were cotransfected with a plasmid expressing TRIP8b including exon 1a and exon 4 (from D.M.C.) and either pAAV-SCR-shRNA-EGFP or pAAV-TRIP8b-shRNA-EGFP using lipofectamine 2000 (ThermoFisher Scientific) according to the manufacturer's protocol. Cells were harvested 72 h post-transfection. 30 µ g cell lysates was electrophoretically separated on a Mini-PROTEAN TGX Gel, 4-15% (Bio-Rad) and transferred to nitrocellulose membranes (LI-COR Bioscience) for 1 h. For quantification of loading control, total protein stain was performed using REVERT Total Protein Stain (LI-COR Bioscience, cat. no. 926-11010), following the manufacturer's instructions. Nitrocellulose membranes were blocked for > 60 min at room temperature with blocking buffer (Licor Odyssey Blocking Buffer) and then were probed overnight at 4 °C with primary antibodies against rabbit anti-TRIP8b antibody (from D.M.C.) and GAPDH (Millipore, cat. no. MAB374) in blocking buffer (LI-COR Odyssey Blocking Buffer). The following day, blots were rinsed and incubated in IRDye 680LT goat anti-mouse IgG (H + L; LI-COR Bioscience, cat. no. P/N 925-68020) and IRDye 800CW donkey anti-rabbit IgG (H + L; LI-COR Bioscience, cat. no. P/N 926-32213) in blocking buffer (Licor Odyssey Blocking Buffer). Immunoreactive bands were visualized using an Odyssey CLx chemifluorescence detector (LI-COR) with quantitation performed using LI-COR Image Studio 5.x. The signal intensity of TRIP8b was normalized to the signal intensity of each lane of total protein staining 60 .
Tissue collection and immunohistochemistry. Mice were anesthetized with chloral hydrate (Sigma-Aldrich, cat. no. C8383, 400 mg/kg, stock solution 400 mg/ml made in 0.9% NaCl solution, i.p.) and underwent intracardial exsanguination with cold 0.1 M PBS (7 ml/min, 6 min) followed by perfusion with 4% paraformaldehyde in 0.1 M PBS (15 min). After subsequent cryoprotection, brains were sectioned coronally on a freezing microtome (Leica), and 30-µ m sections through the entire A/P length of the hippocampus and entorhinal cortex (from bregma: -0.82 to -4.24 mm) were collected. Serial sets of sections were stored in 0.1% NaN 3 in 1 × PBS at 4 °C until processing for slide-mounted immunohistochemistry (IHC) analysis 36, 61 .
For Ki67, DCX, BrdU, GFP, TRIP8b, NeuN, and mCherry IHC, one series of sections was mounted on glass slides (Superfrost/Plus, Fisher) that were coded to ensure experimenters remained blind throughout quantification and analysis of data. Sections were processed for antigen retrieval (0.01 M citric acid, pH 6.0, 95 °C, 15 min), and nonspecific staining was blocked via incubation in blocking solution (3% normal donkey serum (NDS), vol/vol in 0.1% Triton X-100 in 1 × PBS) for 30 min. For BrdU IHC, permeabilization was performed using 0.1% Trypsin in 0.1 M Tris and 0.1% CaCl 2 , and denaturation was performed using 2 N HCl in 1 × PBS before the blocking step. After blocking, sections were incubated with one of the following primary antibodies: rabbit anti-Ki67 (1:500; Thermo Scientific, cat. no. RM-9106), goat anti-DCX (1:500; Santa Cruz, cat. no. SC-8066), rat anti-BrdU (1:800; Accurate Chemicals cat. no. Obt0030), chicken anti-GFP (1:3,000; Aves cat. no. GFP-1020), guinea pig anti-TRIP8b (1:500; from D.M.C.), mouse anti-TRIP8b1a5 (1:500; from D.M.C.), rabbit anti-mCherry (1:1,000; Clontech, cat. no. 632496) in 0.1% Tween-20 in 1 × PBS overnight. For BrdU and NeuN doublelabeling IHC, sections were incubated in mouse anti-NeuN (1:500; Millipore, cat no. MAB377, Billerica, MA) and rat anti-BrdU (1:800; Accurate Chemicals, cat. no. Obt0030). After incubation with primary antibody, sections for single-labeling IHC were rinsed and incubated in the appropriate secondary antibody: biotinylated donkey anti-rabbit IgG (cat. no. 711-065-162), biotinylated donkey anti-goat IgG antibody (cat. no. 705-065-003), biotinylated donkey anti-rat IgG (cat. no. 712-065-153), biotinylated donkey anti-chicken IgY (cat. no. 703-065-155), biotinylated donkey anti-guinea pig IgG (cat. no. 706-065-148) or biotinylated donkey anti-mouse IgG (cat. no. 715-065-150; all 1:200, Jackson ImmunoResearch Laboratories Inc., West Grove, PA) in 1.5% NDS in 1 × PBS for 1 h. After rinses and 30 min in 0.3% hydrogen peroxide in 1 × PBS, sections were incubated in avidin-biotin complex (ABC Elite, Vector Laboratories) for 60 min. After rinsing, staining was visualized using DAB/metal concentration (Thermo Scientific, cat. no. 1856090) or fluorescein-, cyanine-3-,or cyanine-5-labeled Tyramide Signal Amplification (TSA, PerkinElmer, cat. no. SAT701, no. SAT704 or no. SAT705, respectively). For BrdU and NeuN double-labeling IHC, after incubation with a NeuN-targeted primary antibody, sections were incubated in cyanine-5-labeled donkey anti-mouse secondary antibody (Jackson ImmunoResearch Laboratories Inc., cat. no. 715-175-150), fixed with 4% paraformaldehyde for 15 min and then incubated with anti-BrdU primary antibody. This was followed by incubation in biotinylated donkey anti-rat secondary antibody (Jackson ImmunoResearch Laboratories Inc., cat. no. 712-065-153) and then ABC Elite, and immunostaining was finally visualized via incubation in fluorescein-TSA (TSA, PerkinElmer, cat. no. SAT701). Nuclear Fast Red (Vector Laboratories, cat. no. H-3403), DAPI (Roche, cat. no. 236276) or Neurotrace 500/525 green fluorescent Nissl (Invitrogen, cat. no. N-21480) were used as counterstains.
Assessment and quantification of immunoreactive soma and terminals.
Unbiased analysis of Ki67 + , BrdU + , DCX + , GFP + , and c-Fos + cell numbers in the DG was performed via stereologic quantification on a BX51 System Microscope (Olympus America, Center Valley, PA, USA) by an observer blind to experimental condition as previously described 36, 62 . Ki67 + subgranular zone (SGZ) cells, BrdU + granule cell layer (GCL) cells, GFP + SGZ type-1 radial glial-like DG cells, and c-Fos + GCL cells were visualized with a 40 × , 0.63 NA oil-immersion objective. Cell number was quantified with the formula: total population of cells = total cells counted × (1 / ssf) × (1 / asf) × (1 / hsf), where ssf is the section sampling fraction (Ki67: 1/9; BrdU, GFP, and c-Fos: 1/8), asf is the area sampling fraction (1 for the rare populations of Ki67 + , BrdU + , GFP + , and c-Fos + cells; thus, these cells were counted in 1 of every 9th section or 1 of every 8th section throughout the DG), and hsf is the height sampling fraction (1 given the minimal effect edge artifacts have in counting soma < 10 µ m in diameter with ssf 1/9 or 1/8). As Ki67 + cell number was counted in both hemispheres, the resulting formula was: total population of Ki67 + cells = total cells counted × (1 / (1 / 9)) × (1 / 1) × (1 / 1). BrdU, GFP, and c-Fos were counted in one hemisphere, and thus the resulting formula was: total population of BrdU + cells, GFP + cells, or c-Fos + cells = (total cells counted × (1 / (1 / 8)) × (1 / 1) × (1 / 1)) × 2.
For bregma graphs of immunoreactive cells, the number of cells was examined per coronal section over the rostrocaudal axis of the DG, and the x axis displays the distance from bregma in mm. For qualitative assessment of TRIP8b protein expression in specific brain regions of wild-type mice and TRIP8b knockout mice ( Supplementary Fig. 2i ), relative TRIP8b protein expression in the parietal cortex, Ent, and hippocampal subregions was examined via epifluorescence under magnification (400 × ) and were ranked from -(not detected) to + + + (greatest relative expression). For assessment of GFP or mCherry protein expression in specific brain regions after infusion of virus in the Ent (Figs. 2-5 and Supplementary Figs. 2 and 4-11) , stained sections were examined for the presence of GFP + or mCherry + soma or terminals via epifluorescence under magnification (400 × ).
For c-Fos + cell density in the Ent, cells were visualized with a 20 × objective, and images of c-Fos + cells in lEnt and mEnt (two images per subject; n = 5 mCherry-infused mice and 4 hM3Dq-infused mice) were taken using a DP74 camera with Cellsens software (Olympus America, Center Valley, PA, USA) and cell number was quantified using ImageJ software with automated analysis (National Institutes of Health, Bethesda, Maryland, USA) 63 .Cross-sectional areas Articles NaTurE MEDIcINE of the lEnt and mEnt were measured using Cellsens standard software (ver. 1.16, Olympus America, Center Valley, PA, USA).
For the DCX + population of GCL cells, which were not rare, cells were visualized with a 0.75 NA (DCX) oil-immersion objective. The Optical Fractionator Probe within Stereo Investigator software (ver. 11.03, MBF Bioscience, Williston, VT, USA) was then applied, and an unbiased counting frame was superimposed on the region of interest using a MicroFIRE A/R camera (Optronics, Goleta, CA, USA). To account for tissue shrinkage, an optical dissector height of 12 µ m was applied. The number of DCX + cells in tissue from Trip8b knockout and control mice was counted in both hemispheres, and the number of DCX + cells in tissue from TRIP8b-shRNA-infused and SCR-shRNA-infused mice were counted in one hemisphere. As the ssf was 1/9 (Trip8b knockout mice studies) or 1/8 (TRIP8b shRNA studies), total counts were multiplied by 9 or 16 to obtain the total number of DCX + GCL or DG cells.
Confocal microscopy and colocalization analyses. Colocalization of immunoreactive cells was assessed by an observer blinded to experimental condition using confocal microscopy (LSM510-META, Carl Zeiss, Oberkochen, Germany; emission wavelengths were 488 nm and 633 nm) 64 . Analyses were performed using a 63× , 1.2-NA water-immersion lens. 50-100 BrdU + cells were analyzed in five or six brain sections from the anterior, middle, and posterior hippocampal GCL of each mouse and were classified as NeuN + or NeuNthrough analysis of adjacent Z-sections, orthogonal sectioning through Z-sections, and 3D reconstruction with rotation. The percent of BrdU + cells that were also NeuN + in each mouse was multiplied by the total number of BrdU + cells for each mouse, which was obtained via stereology. The resulting numbers of BrdU + NeuN + cells for each mouse were combined for each group and subjected to statistical analysis.
Dendritic tree reconstruction. Dendrite and cell body morphological analyses of DCX + neurons stained with DAB were performed by an observer blind to experimental condition using NeuroLucida software (ver. 10, MBF Bioscience) on a BX51 System Microscope (Olympus America, Center Valley, PA, USA) and a 40 × , 0.75-NA oil-immersion lens with a MicroFIRE A/R camera (Optronics, Goleta, CA, USA). DCX + cells selected for tracing had three or more nodes, and the cell body and branches were visible within the thickness of the section. The dendritic tree and cell body of each cell was traced in its entirety with an unbiased systematic random sampling of the visual field 20 . 6-8 DCX + neurons from anterior (-1.46 to -2.06 mm from bregma) and posterior (-2.76 to -3.28 mm from bregma) DG sections that were spaced equally throughout the A/P axis of the hippocampus were analyzed. The coordinate files generated through 3D reconstruction were analyzed in NeuroLucida Explorer, generating morphologic measurements for each neuron that included cell body cross section, dendrite length and surface area, number of nodes and endings, and maximum branch order.
Behavioral tests. Brief descriptions of the behavioral tests are provided below. Male or female mice were used for behavioral tests, as described below, and behavior tests were done during the light cycle unless otherwise noted. Behavioral scoring was done by a single rater, blind to the treatment condition.
Chronic social defeat stress and social interaction test. Exposure to social defeat and subsequent interaction testing was performed as described previously 18, 25, 36 . Retired male CD1 breeders (4-6 months old; Charles River Laboratories, Wilmington, MA) were screened for aggressiveness. If a CD1 mouse took < 60 s to attack a test mouse (C57BL/6 J mouse) placed into the home cage and displayed this latency to attack for two consecutive days, the CD1 mouse was determined to be aggressive. For CSDS, a CD1 aggressor mouse was housed on one side of a cage, which was partitioned with a plastic divider, and a test mouse (C57BL/6 J or CamKIIα -iCre) was placed on the other side of the divider. Two to three hours before the onset of the dark cycle, the 'defeat' bout was triggered by removing the plastic divider for 5 (C57BL/6 J experiments) or 10 (CamKIIα -iCre experiments) min, which allowed the CD1 aggressor to physically attack the test mouse. The test mouse was moved to a different cage opposite a new aggressor either after the defeat bout (C57BL/6 J experiments) or immediately before the next defeat (CamKIIα -iCre experiments) in order to instill generalization of stress-induced defeat to the CD1 strain, not to just a single aggressor. Control mice were housed in partitioned cages identical to those used for defeat, but they were housed opposite to one other control mouse. Control mice were handled each day at the same time of day as when the defeat was performed. The defeats or handling continued daily for 10 d.
On day 11 (24 h after the last day of the 10-d CSDS), social interaction was measured via two trials lasting 150 s each. Test mice were individually placed in the new environment of a white open-field chamber (length, 45 cm × width, 45 cm × height, 30 cm) with a discrete 'interaction zone' against one wall (length, 14 cm × width, 26 cm) that encompassed an empty plastic enclosure (length, 6.5 cm × width, 10 cm × height, 42 cm; Nationwide Plastics custom order). For the first trial (2 min 30 s in duration), the mouse was placed randomly into either corner opposite to the interaction zone, and the movements of the mouse were tracked using Ethovision software (Noldus Information Technology). Specifically, the time the mouse spent in the interaction zone or corners opposite to the interaction zone was quantified. For the second trial, which was also 2 min 30 s in duration and which began ~30 s after the first trial was completed, an unfamiliar CD1 aggressor mouse was placed into the plastic enclosure in the interaction zone. The SI ratio was calculated as follows: SI = (time spent in interaction zone with aggressor mouse) / (time spent in interaction zone with empty enclosure present). Mice with a SI ratio < 1 were categorized as susceptible, and mice with a SI ratio ≥ 1 were categorized as resilient. The distribution of SI ratios is shown in Supplementary Fig. 3f , and the weights of the mice on Day 1 and 11 of CSDS is shown in Supplementary Fig. 3g . Immediately after testing for SI, mice were singly housed until they were euthanized 24 h later.
Locomotor test. Mice were individually placed in a cage with fresh bedding, and the cage was placed between photocells under dim or red lights during the light cycle and under red lights during the dark cycle. A computer-controlled photobeam activity system (San Diego Instruments) recorded the total movement of mice in the XY plane; photocell beam breaks were recorded in 5-min bins for 17 or 20 h. In Fig. 3i , one mouse from the TRIP8b/IRR group was excluded due to a husbandry error (the water bottle flooded the cage during the locomotor test).
Restraint stress. Except for under the basal condition ( Fig. 3a-e ) or under conditions that modeled stress (CORT, Fig. 4a-g ; CSDS experiments, Fig. 5s-t) , mice were restrained for 30 min before depressive-like behavior tests (i.e., forced swim test and novelty-suppressed feeding test) 24 . The restraint apparatus (50-ml falcon tube) restricted movement but did not interfere with normal breathing, as it was modified with numerous holes.
Forced swim test. The forced swim test was performed to evaluate behavioral despair induced by stress, as previously described 65, 66 . Mice were placed in a 5-L beaker (Corning Inc. Life Sciences, Lowell, MA, USA) that was filled with 4 L of 25 ± 2 °C water, and the entire session was videotaped. For the last 4 min (Fig. 3c 24, 35 . A mouse was placed in a corner of the arena and allowed to explore for up to 12 min. The trial ended when the mouse initially bit and consumed the chow. After the NSF test, the mouse was immediately removed from the test arena and placed individually in the home cage where it was presented with a preweighed amount of chow for 5 min. The food was weighed at the end of the session, and the amount consumed (difference) was recorded in grams.
Contextual fear conditioning test and cue fear conditioning test.
Context-and cuedependent fear conditioning experiments were performed using a contextual conditioning system (Med Associates, St. Albans, VT, USA) as previously described 64 . Mice were trained and tested in the contextual and cued fear conditions within the chamber (length, 25 cm × width, 29 cm × height, 25 cm) with clear plastic walls and ceilings and a standard floor made of metal bars. For training, after 2-min habituation, a tone was presented (80 dB white noise, 30 s), which co-terminated with a footshock (0.5 mA, 2 s). The tone-shock pairing was repeated for a total of three shocks over 6 min with a 1-min interval between tone presentations. For the contextual conditioning test, 24 h after training, mice were placed into the training context for 5 min, but the tone and shock were not presented. For the cued conditioning test, 48 h after training, mice were placed in a new environment (plastic floor over the grid bars, triangle roof, vanilla scent) for 6 min, with the tone presented continuously for the last 3 min. Scoring of freezing behavior was automatically performed by the Med Associates software using a threshold of 20 arbitrary units and minimum freeze duration of 0.5 s.
Dark-light test. The apparatus consisted of a polypropylene cage (length, 44 cm × width, 21 cm × height, 21 cm) unequally divided into two chambers (two-thirds and one-third of the space) by a wall with a small vestibule. The large chamber was open, transparent, and brightly illuminated by two 20-W fluorescent lights (measured as 1,388 lux at cage floor), and the small chamber was closed, painted black, and dark. Initially, the mouse was placed in the dark side for 2 min, and the transitions of the mouse between the two chambers were automatically detected via four photocells located in the vestibule over 10 min. The time spent in the brightly lit side and the latency to enter the brightly lit side were measured by the automated system.
Elevated plus maze. The apparatus was built (elevation, 99 cm; two open and two closed arms, each length, 67 cm × width, 6 cm; closed arm walls, height, 17 cm) as previously described 67 . Mice were placed in the center of the apparatus and allowed to freely explore for 5 
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Clearly defined error bars
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For western blot analysis, Scion image software (Scion Corporation) or LI-COR Image studio 5. For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
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Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
All materials used in this work are readily available from the authors or standard commercial sources (which are provided in the text). b. Describe the method of cell line authentication used. ATCC uses morphology, karyotyping, and PCR based approaches to confirm the identity of human cell lines and to rule out both intra-and interspecies contamination. These include an assay to detect species specific variants of the cytochrome C oxidase I gene (COI analysis) to rule out inter-species contamination and short tandem repeat (STR) profiling to distinguish between individual human cell lines and rule out intra-species contamination.
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At the ATCC, both the Hoechst and direct culture method techniques are used several times while a cell line is accessioned and again when the culture is expanded for distribution.
d. If any of the cell lines used are listed in the database of commonly misidentified cell lines maintained by ICLAC, provide a scientific rationale for their use.
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Provide details on animals and/or animal-derived materials used in the study. 7 or 8 weeks old C57BL/6J male or female mice were purchased from Jackson Laboratory (stock number: 000664). Nestin-GFP mice were bred at UTSW, and CamKIIα-icre mice were bred at UTSW and PennMed/CHOP, resulting in hemizygous transgenic mice. CamKIIa-icre and nestin-GFP mice were originally from Schutz's lab and Mori's lab, respectively, and original references are provided in the text. Trip8b germline knock-out mice were generated by the Chetkovich Laboratory by breeding heterozygous Trip8b+/-mice.
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